Elkfork Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $689K | Buy |
2,523
+356
| +16% | +$97.2K | 0.02% | 490 |
|
|
2019
Q2 | $1.16M | Sell |
2,167
-741
| -25% | -$396K | 0.03% | 366 |
|
|
2019
Q1 | $1.47M | Sell |
2,908
-6,918
| -70% | -$3.49M | 0.04% | 313 |
|
|
2018
Q4 | $4.85M | Buy |
9,826
+1,872
| +24% | +$923K | 0.14% | 152 |
|
|
2018
Q3 | $7.27M | Buy |
7,954
+7,038
| +768% | +$6.44M | 0.17% | 124 |
|
|
2018
Q2 | $671K | Buy |
916
+624
| +214% | +$457K | 0.02% | 446 |
|
|
2018
Q1 | $466K | Sell |
292
-1,263
| -81% | -$2.02M | 0.01% | 545 |
|
|
2017
Q4 | $1.39M | Buy |
1,555
+265
| +21% | +$237K | 0.04% | 299 |
|
|
2017
Q3 | $464K | Buy |
1,290
+175
| +16% | +$62.9K | 0.01% | 507 |
|
|
2017
Q2 | $327K | Buy |
1,115
+480
| +76% | +$141K | 0.01% | 585 |
|
|
2017
Q1 | $223K | Buy |
635
+64
| +11% | +$22.5K | 0.01% | 569 |
|
|
2016
Q4 | $105K | Buy |
+571
| New | +$105K | ﹤0.01% | 728 |
|